JAN 09, 2018 6:42 AM PST

Protecting Against Glioblastoma

WRITTEN BY: Carmen Leitch

Researchers at the Spanish National Cancer Research Centre (CNIO) have made progress in the fight against glioblastoma. They found that a protein, RanBP6, regulates a receptor that has a role in human development and cancer, epidermal growth factor receptor (EGFR). Reporting in Nature Communications, they found that by silencing RanBP6, glioma growth was promoted because EGFR expression was increased.  

Macroscopic pathology of Glioblastoma multiforme / Credit: Wikimedia Commons / Sbrandner

Of the roughly 100,00 new cases of malignant brain tumors that are diagnosed every year, glioblastoma is the deadliest and most common type of adult primary central nervous system tumor. The genome of glioma cells has been found to be incredibly complicated, however, and the effect of the many genetic mutations that arise is not known.

The Seve Ballesteros Foundation-CNIO Brain Tumor Group, headed by Massimo Squatrito, in collaboration with the laboratory of Ingo Mellinghoff at the Memorial Sloan-Kettering Cancer Center in New York, has now uncovered a novel mechanism that contributes to preventing glioblastoma development.

EGFR has a critical role in normal development, as well as in human cancer, making it a major drug target in cancer therapeutics. Dysfunctional activation of EGFR can cause tumors to grow. It has been suggested that increases in gene copy numbers and gain-of-function mutations are to blame, but problems in the regulation of EGFR can also be a cause.

Study co-lead authors Barbara Oldrini and Wan-Ying Hsieh found a new player in EGFR regulation. An uncharacterized protein, RanBP6, was identified as a modulator of EGFR expression. RanBP6 is a member of the importin family that regulates the import of signal transducer and activator of transcription 3 (STAT3) to the nucleus. When RanBP6 is halted, STAT3 nuclear translocation is impaired; then there is less transcription of EGFR, increasing EGFR pathway output.

"Our studies showed for the first time that STAT3 is a direct inhibitor of EGFR expression. I believe this has important clinical implications: STAT3 inhibitors are currently being investigated for the treatment of glioblastoma and other tumor types. Inhibiting STAT3 signaling could lead to an undesired activation of EGFR signaling,” explained Massimo Squatrito.

Some deletions of RanBP6 were found in some glioblastoma patients. Silencing RanBP6 caused growth glioma in a mouse glioma model, due to an upregulation of EGFR.

"Our results provide an example of EGFR deregulation in cancer through silencing of components of the nuclear import pathway. We have identified a new link between the Ran-GTPase nuclear transport pathway and key cancer signaling pathways which warrant further study as inhibitors targeting nuclear transporters enter clinical evaluation as cancer therapeutics,” concluded Barbara Oldrini.


This group has been working to treat brain tumors for years; learn more about their lab from the video.

Sources: AAAS/Eurekalert! Via CNIO, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 07, 2021
Cell & Molecular Biology
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
JUN 07, 2021
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
Researchers are increasingly relying on cells grown in three-dimensional (3D) structures to help answer their research q ...
JUN 08, 2021
Neuroscience
Simple Blood Test Can Detect Depression and Underlying Neurodegeneration
JUN 08, 2021
Simple Blood Test Can Detect Depression and Underlying Neurodegeneration
Researchers led by King’s College London have found that levels of a protein known as neurofilament light chain (N ...
JUN 25, 2021
Genetics & Genomics
Towards More Efficient Plant Engineering with CRISPR-Cas9 Gene Drive
JUN 25, 2021
Towards More Efficient Plant Engineering with CRISPR-Cas9 Gene Drive
Many people in the world don't have access to enough food. And while humans might find ways to adapt to a changing world ...
JUL 01, 2021
Cell & Molecular Biology
A Better Understanding of VLCADD May Improve Treatment
JUL 01, 2021
A Better Understanding of VLCADD May Improve Treatment
With newborn screenings, clinicians can now identify newly born infants that carry genetic mutations that will lead to d ...
JUL 09, 2021
Cell & Molecular Biology
Wearable Tech for...Plants?
JUL 09, 2021
Wearable Tech for...Plants?
Researchers have developed a "wearable" patch to detect the gaseous substances plants emit when diseased or stressed,
JUL 17, 2021
Microbiology
Fungi Can be a Healthy or Destructive Part of the Gut Microbiome
JUL 17, 2021
Fungi Can be a Healthy or Destructive Part of the Gut Microbiome
Scientists have been revealing the importance of gut bacteria; the huge numbers of bacterial species in our gastrointest ...
Loading Comments...